Markus Hansson

affiliated with the university, ConsultantFormer name: M Hansson
More filtering options
  1. 2020
  2. Genetic predisposition for multiple myeloma

    Maroulio Pertesi, Went, M., Markus Hansson, Kari Hemminki, Houlston, R. S. & Björn Nilsson, 2020 Jan 8, In : Leukemia.

    Research output: Contribution to journalReview article

  3. Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

    Wålinder, G., Samuelsson, J., Näsman, P., Markus Hansson, Gunnar Juliusson, Forsberg, K., Svensson, R., Linder, O., Carlson, K., Kristinsson, S. Y., Mellqvist, U. H., Hveding Blimark, C., Ingemar Turesson & Nahi, H., 2020, In : European Journal of Haematology. 104, 5, p. 376-382 7 p.

    Research output: Contribution to journalArticle

  4. Search for multiple myeloma risk factors using Mendelian randomization

    Went, M., Cornish, A. J., Law, P. J., Kinnersley, B., van Duin, M., Weinhold, N., Asta Försti, Markus Hansson, Sonneveld, P., Goldschmidt, H., Morgan, G. J., Kari Hemminki, Björn Nilsson, Kaiser, M. & Houlston, R. S., 2020, In : Blood Advances. 4, 10, p. 2172-2179 8 p.

    Research output: Contribution to journalArticle

  5. 2019
  6. Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

    Thomas Hellmark, Sophie Ohlsson, Pettersson, Å., Markus Hansson & Johansson, Å. C. M., 2019 Mar, In : BMC Rheumatology. 3, 9, 12 p.

    Research output: Contribution to journalArticle

  7. All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

    Dimopoulos, M. A., Grosicki, S., Jędrzejczak, W. W., Nahi, H., Gruber, A., Markus Hansson, Gupta, N., Byrne, C., Labotka, R., Teng, Z., Yang, H., Grzasko, N. & Kumar, S., 2019, In : European Journal of Cancer. 106, p. 89-98 10 p.

    Research output: Contribution to journalArticle

  8. Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes

    Went, M., Kinnersley, B., Sud, A., Johnson, D. C., Weinhold, N., Försti, A., van Duin, M., Orlando, G., Mitchell, J. S., Kuiper, R., Walker, B. A., Gregory, W. M., Hoffmann, P., Jackson, G. H., Nöthen, M. M., Inacio da Silva Filho, M., Thomsen, H., Broyl, A., Davies, F. E., Thorsteinsdottir, U. & 9 others, Markus Hansson, Kaiser, M., Sonneveld, P., Goldschmidt, H., Stefansson, K., Hemminki, K., Björn Nilsson, Morgan, G. J. & Houlston, R. S., 2019, In : Human Genomics. 13, 1, 37.

    Research output: Contribution to journalArticle

  9. 2018
  10. Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

    Went, M., Sud, A., Speedy, H., Sunter, N. J., Försti, A., Law, P. J., Johnson, D. C., Mirabella, F., Holroyd, A., Li, N., Orlando, G., Weinhold, N., van Duin, M., Chen, B., Mitchell, J. S., Mansouri, L., Juliusson, G., Smedby, K. E., Jayne, S., Majid, A. & 35 others, Dearden, C., Allsup, D. J., Bailey, J. R., Pratt, G., Pepper, C., Fegan, C., Rosenquist, R., Kuiper, R., Stephens, O. W., Bertsch, U., Broderick, P., Einsele, H., Gregory, W. M., Hillengass, J., Hoffmann, P., Jackson, G. H., Jöckel, K. H., Nickel, J., Nöthen, M. M., da Silva Filho, M. I., Hauke Thomsen, Walker, B. A., Broyl, A., Davies, F. E., Markus Hansson, Goldschmidt, H., Dyer, M. J. S., Kaiser, M., Sonneveld, P., Morgan, G. J., Kari Hemminki, Björn Nilsson, Catovsky, D., Allan, J. M. & Houlston, R. S., 2018 Dec 21, In : Blood Cancer Journal. 9, 1, 1.

    Research output: Contribution to journalArticle

  11. A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

    A. Ljungars, Mårtensson, L., Jenny Mattsson, Kovacek, M., Sundberg, A., Tornberg, U-C., B. Jansson, Persson, N., V. Kuci Emruli, S. Ek, M. Jerkeman, M. Hansson, G. Juliusson, M. Ohlin, Frendéus, B., Teige, I. & Mattsson, M., 2018 Dec 1, In : JCO Precision Oncology. 2, 1

    Research output: Contribution to journalArticle

  12. The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression

    Ali, M., Ram Ajore, Anna Karin Wihlborg, Abhishek Niroula, Swaminathan, B., Ellinor Johnsson, Stephens, O. W., Morgan, G., Meissner, T., Ingemar Turesson, Goldschmidt, H., Mellqvist, U. H., Urban Gullberg, Markus Hansson, Kari Hemminki, Nahi, H., Waage, A., Weinhold, N. & Björn Nilsson, 2018 Dec 1, In : Nature Communications. 9, 1, 1649.

    Research output: Contribution to journalArticle

  13. Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma

    Lund, J., Gruber, A., Lauri, B., Duru, A. D., Blimark, C., Swedin, A., Markus Hansson, Forsberg, K., Ahlberg, L., Carlsson, C., Waage, A., Gimsing, P., Vangsted, A. J., Frølund, U., Holmberg, E., Gahrton, G., Alici, E., Hardling, M., Mellqvist, U. H. & Nahi, H., 2018 Jan 1, In : Cancer Medicine.

    Research output: Contribution to journalArticle

  14. Bone marrow eosinophils in plasma cell disorders

    Stina Wichert, Pettersson, Å., Thomas Hellmark, Johansson, Å. & Markus Hansson, 2018, In : Experimental Hematology. 66, p. 27-31.e5

    Research output: Contribution to journalArticle

  15. 2017
  16. Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1

    Mateos, M-V., Masszi, T., Grzasko, N., Markus Hansson, Sandhu, I., Pour, L., Viterbo, L., Jackson, S. R., Stoppa, A-M., Gimsing, P., Hamadani, M., Borsaru, G., Berg, D., Lin, J., Di Bacco, A., van de Velde, H., Richardson, P. G. & Moreau, P., 2017 Oct, In : Haematologica. 102, 10, p. 1767-1775 9 p.

    Research output: Contribution to journalArticle

  17. Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

    Moreau, P., Dimopoulos, M. A., Richardson, P. G., Siegel, D. S., Cavo, M., Corradini, P., Weisel, K. C., Delforge, M., O'Gorman, P., Song, K., Chen, C., Bahlis, N., Oriol, A., Hansson, M., Kaiser, M., Anttila, P., Raymakers, R., Joao, C., Cook, G., Sternas, L. & 7 others, Biyukov, T., Slaughter, A., Hong, K., Herring, J., Yu, X., Zaki, M. H. & San Miguel, J., 2017 Sep 1, In : European Journal of Haematology. 99, 3, p. 199-206 8 p.

    Research output: Contribution to journalArticle

  18. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

    Nahi, H., Genell, A., Wålinder, G., Uttervall, K., Gunnar Juliusson, Karin, F., Markus Hansson, Svensson, R., Linder, O., Carlson, K., Björkstrand, B., Kristinsson, S. Y., Mellqvist, U-H., Blimark, C. & Ingemar Turesson, 2017 Sep, In : European Journal of Haematology. 99, 3, p. 216-222

    Research output: Contribution to journalArticle

  19. NOX2-dependent immunosuppression in chronic myelomonocytic leukemia

    Aurelius, J., Hallner, A., Werlenius, O., Riise, R., Möllgård, L., Brune, M., Markus Hansson, Martner, A., Thorén, F. B. & Hellstrand, K., 2017 Aug, In : Journal of Leukocyte Biology. 102, 2, p. 459-466

    Research output: Contribution to journalArticle

  20. Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach

    Went, M., Sud, A., Law, P. J., Johnson, D. C., Weinhold, N., Försti, A., van Duin, M., Mitchell, J. S., Chen, B., Kuiper, R., Stephens, O. W., Bertsch, U., Campo, C., Einsele, H., Gregory, W. M., Henrion, M., Hillengass, J., Hoffmann, P., Jackson, G. H., Lenive, O. & 16 others, Nickel, J., Nöthen, M. M., da Silva Filho, M. I., H. Thomsen, Walker, B. A., Broyl, A., Davies, F. E., Langer, C., M. Hansson, Kaiser, M., Sonneveld, P., Goldschmidt, H., K. Hemminki, B. Nilsson, Morgan, G. J. & Houlston, R. S., 2017 Jun 16, In : Blood Cancer Journal. 7, 6, p. e573

    Research output: Contribution to journalLetter

  21. Direct evidence for a polygenic etiology in familial multiple myeloma

    Halvarsson, B-M., Wihlborg, A-K., Ali, M., Lemonakis, K., Johnsson, E., Niroula, A., Cibulskis, C., Weinhold, N., Försti, A., Alici, E., Langer, C., Pfreundschuh, M., Goldschmidt, H., Mellqvist, U-H., Turesson, I., Waage, A., Hemminki, K., Golub, T., Nahi, H., Gullberg, U. & 2 others, Markus Hansson & Björn Nilsson, 2017 Apr 11, In : Blood Advances. 1, 10, p. 619-623

    Research output: Contribution to journalArticle

  22. Identification of sequence variants influencing immunoglobulin levels

    Jonsson, S., Sveinbjornsson, G., de Lapuente Portilla, A. L., Swaminathan, B., Plomp, R., Dekkers, G., Ajore, R., Ali, M., Bentlage, A. E. H., Elmér, E., Eyjolfsson, G. I., Gudjonsson, S. A., Gullberg, U., Gylfason, A., Halldorsson, B. V., Hansson, M., Holm, H., Johansson, Å., Johnsson, E., Jonasdottir, A. & 18 others, Ludviksson, B. R., Oddsson, A., Olafsson, I., Olafsson, S., Sigurdardottir, O., Sigurdsson, A., Stefansdottir, L., Masson, G., Sulem, P., Wuhrer, M., Anna-Karin Wihlborg, Thorleifsson, G., Gudbjartsson, D. F., Thorsteinsdottir, U., Vidarsson, G., Jonsdottir, I., Björn Nilsson & Stefansson, K., 2017, In : Nature Genetics. 49, 8, p. 1182-1191

    Research output: Contribution to journalArticle

  23. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    Dimopoulos, M. A., Kastritis, E., Terpos, E., Nahi, H., Goldschmidt, H., Hillengass, J., Leleu, X., Beksac, M., Alsina, M., Oriol, A., Cavo, M., Ocio, E. M., Mateos, M. V., O'Donnell, E. K., Vij, R., Lokhorst, H. M., van de Donk, N. W. C. J., Cam-min, J., Mark, T., Turesson, I. & 21 others, Markus Hansson, Jagannath, S., Delforge, M., Kyriakou, C., Hari, P., Mellqvist, U. H., Usmani, S. Z., Dytfeld, D., Badros, A. Z., Otero, P. R., Shustik, C., Waller, D., Chng, W-J., Ozaki, S., de la Rubia, J., Eom, H. S., Rosinol, L., Lahuerta, J. J., Sureda, A., Kim, J. S. & Durie, B. G. M., 2017, In : Leukemia. 31, p. 2443-2448

    Research output: Contribution to journalArticle

  24. 2016
  25. Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): A phase 3b study in refractory multiple myeloma

    Dimopoulos, M. A., Palumbo, A., Corradini, P., Cavo, M., Delforge, M., Di Raimondo, F., Weisel, K. C., Oriol, A., Hansson, M., Vacca, A., Blanchard, M. J., Goldschmidt, H., Doyen, C., Kaiser, M., Petrini, M., Anttila, P., Cafro, A. M., Raymakers, R., San-Miguel, J., De Arriba, F. & 11 others, Knop, S., Röllig, C., Ocio, E. M., Morgan, G., Miller, N., Simcock, M., Peluso, T., Herring, J., Sternas, L., Zaki, M. H. & Moreau, P., 2016 Jul 28, In : Blood. 128, 4, p. 497-503 7 p.

    Research output: Contribution to journalArticle

  26. Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma

    Moreau, P., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., Pour, L., Sandhu, I., Ganly, P., Baker, B. W., Jackson, S. R., Stoppa, A. M., Simpson, D. R., Gimsing, P., Palumbo, A., Garderet, L., Cavo, M., Kumar, S., Touzeau, C., Buadi, F. K., Laubach, J. P. & 21 others, Berg, D. T., Lin, J., Di Bacco, A., Hui, A. M., Van De Velde, H., Richardson, P. G., Kupperman, E., Berger, A., Dick, L., Williamson, M., Chauhan, D., Anderson, K., Esseltine, D. L., Niculescu, L., Taraskiewicz, S., Stecklair, J., Lonial, S., Rajkumar, V., Miquel, J. S., Einsele, H. & Orlowski, R., 2016 Apr 28, In : New England Journal of Medicine. 374, 17, p. 1621-1634 14 p.

    Research output: Contribution to journalArticle

  27. Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden

    Sixten Borg, Nahi, H., Markus Hansson, Lee, D., Elvidge, J. & Persson, U., 2016, In : Acta Oncologica. 55, 5, p. 554-560

    Research output: Contribution to journalArticle

  28. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma

    Mitchell, J. S., Li, N., Weinhold, N., Försti, A., Ali, M., van Duin, M., Thorleifsson, G., Johnson, D. C., Chen, B., Halvarsson, B-M., Gudbjartsson, D. F., Kuiper, R., Stephens, O. W., Bertsch, U., Broderick, P., Campo, C., Einsele, H., Gregory, W. A., Gullberg, U., Henrion, M. & 38 others, Hillengass, J., Hoffmann, P., Jackson, G. H., Ellinor Johnsson, Magnus Jöud, Kristinsson, S. Y., Lenhoff, S., Lenive, O., Mellqvist, U-H., Migliorini, G., Nahi, H., Nelander, S., Nickel, J., Nöthen, M. M., Rafnar, T., Ross, F. M., da Silva Filho, M. I., Swaminathan, B., Thomsen, H., Ingemar Turesson, Vangsted, A., Vogel, U., Waage, A., Walker, B. A., Anna-Karin Wihlborg, Broyl, A., Davies, F. E., Thorsteinsdottir, U., Langer, C., Markus Hansson, Kaiser, M., Sonneveld, P., Stefansson, K., Morgan, G. J., Goldschmidt, H., Kari Hemminki, Björn Nilsson & Houlston, R. S., 2016, In : Nature Communications. 7, 12050.

    Research output: Contribution to journalArticle

  29. Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.

    Zweegman, S., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G. M. J., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A. W. G., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S. K., Tanis, B. C., Szatkowski, D. L., Brouwer, R. E., Westerman, M., Leys, M. R. B. L., Sinnige, H. A. M. & 8 others, Haukås, E., van der Hem, K. G., Durian, M. F., Mattijssen, E. V. J. M., van de Donk, N. W. C. J., Stevens-Kroef, M. J. P. L., Sonneveld, P. & Waage, A., 2016, In : Blood. 127, 9, p. 1109-1116

    Research output: Contribution to journalArticle

  30. 2015
  31. Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.

    Roghanian, A., Teige, I., Mårtensson, L., Cox, K. L., Kovacek, M., Ljungars, A., Mattson, J., Sundberg, A., Vaughan, A. T., Shah, V., Smyth, N. R., Sheth, B., Chan, H. T. C., Li, Z-C., Williams, E. L., Manfredi, G., Oldham, R. J., Mockridge, C. I., James, S. A., Dahal, L. N. & 12 others, Hussain, K., Björn Nilsson, Verbeek, J. S., Gunnar Juliusson, Markus Hansson, Mats Jerkeman, Johnson, P. W. M., Davies, A., Beers, S. A., Glennie, M. J., Frendéus, B. & Cragg, M. S., 2015, In : Cancer Cell. 27, 4, p. 473-488

    Research output: Contribution to journalArticle

  32. A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.

    Markus Hansson, Gimsing, P., Badros, A. Z., Martinsson Niskanen, T., Nahi, H., Offner, F., Salomo, M., Sonesson, E., Mau-Sorensen, M., Stenberg, Y., Sundberg, A., Teige, I., van Droogenbroeck, J., Wichert, S., Zangari, M., Frendeus, B., Korsgren, M., Poelman, M. & Tricot, G., 2015, In : Clinical Cancer Research. 21, 12, p. 2730-2736

    Research output: Contribution to journalArticle

  33. Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.

    Safavi, S., Linda Olsson, Biloglav, A., Srinivas Veerla, Blendberg, M., Tayebwa, J., Behrendtz, M., Anders Castor, Markus Hansson, Bertil Johansson & Kajsa Paulsson, 2015, In : Oncotarget. 6, 40

    Research output: Contribution to journalArticle

  34. Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.

    Lokhorst, H. M., Plesner, T., Laubach, J. P., Nahi, H., Gimsing, P., Hansson, M., Minnema, M. C., Lassen, U., Krejcik, J., Palumbo, A., van de Donk, N. W. C. J., Ahmadi, T., Khan, I., Uhlar, C. M., Wang, J., Sasser, A. K., Losic, N., Lisby, S., Basse, L., Brun, N. & 1 others, Richardson, P. G., 2015, In : New England Journal of Medicine. 373, 13, p. 1207-1219

    Research output: Contribution to journalArticle

  35. Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

    Swaminathan, B., Thorleifsson, G., Jöud, M., Ali, M., Johnsson, E., Ajore, R., Sulem, P., Halvarsson, B-M., Eyjolfsson, G., Haraldsdottir, V., Hultman, C., Ingelsson, E., Kristinsson, S. Y., Kähler, A. K., Lenhoff, S., Masson, G., Mellqvist, U-H., Månsson, R., Nelander, S., Olafsson, I. & 14 others, Sigurðardottir, O., Steingrimsdóttir, H., Vangsted, A., Vogel, U., Waage, A., Nahi, H., Gudbjartsson, D. F., Rafnar, T., Ingemar Turesson, Urban Gullberg, Stefánsson, K., Markus Hansson, Thorsteinsdóttir, U. & Björn Nilsson, 2015, In : Nature Communications. 6, p. 1-8 7213.

    Research output: Contribution to journalArticle

  36. 2014
  37. Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma.

    Dimopoulos, M. A., Leleu, X., Palumbo, A., Moreau, P., Delforge, M., Cavo, M., Ludwig, H., Morgan, G. J., Davies, F. E., Sonneveld, P., Schey, S. A., Zweegman, S., Markus Hansson, Weisel, K., Mateos, M. V., Facon, T. & San Miguel, J. F., 2014, In : Leukemia. 28, 8, p. 1573-1585

    Research output: Contribution to journalReview article

  38. Robust isolation of malignant plasma cells in multiple myeloma.

    Ildiko Frigyesi, Adolfsson, J., Ali, M., Christophersen, M. K., Ellinor Johnsson, Ingemar Turesson, Urban Gullberg, Markus Hansson & Björn Nilsson, 2014, In : Blood. 123, 9, p. 1336-1340

    Research output: Contribution to journalArticle

  39. 2013
  40. A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.

    Veitonmäki, N., Markus Hansson, Zhan, F., Sundberg, A., Löfstedt, T., Ljungars, A., Li, Z-C., Martinsson-Niskanen, T., Zeng, M., Yang, Y., Danielsson, L., Kovacek, M., Lundqvist, A., Mårtensson, L., Teige, I., Tricot, G. & Frendéus, B., 2013, In : Cancer Cell. 23, 4, p. 502-515

    Research output: Contribution to journalArticle

  41. 2012
  42. Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis

    Aurelius, J., Thoren, F. B., Akhiani, A. A., Brune, M., Palmqvist, L., Markus Hansson, Hellstrand, K. & Martner, A., 2012, In : Blood. 119, 24, p. 5832-5837

    Research output: Contribution to journalArticle

  43. Remission maintenance in acute myeloid leukemia: impact of functional histamine H-2 receptors expressed by leukemic cells

    Aurelius, J., Martner, A., Brune, M., Palmqvist, L., Markus Hansson, Hellstrand, K. & Thoren, F. B., 2012, In : Haematologica. 97, 12, p. 1904-1908

    Research output: Contribution to journalArticle

  44. 2010
  45. Neutrophil elastase and proteinase 3 trafficking routes in myelomonocytic cells.

    Källquist, L., Rosén, H., Pontus Nordenfelt, Calafat, J., Janssen, H., Persson, A-M., Markus Hansson & Inge Olsson, 2010, In : Experimental Cell Research. Okt, p. 3182-3196

    Research output: Contribution to journalArticle

  46. 2009
  47. 2008
  48. The tetraspanin CD63 is involved in granule targeting of neutrophil elastase.

    Källquist, L., Markus Hansson, Persson, A-M., Janssen, H., Calafat, J., Tapper, H. & Inge Olsson, 2008, In : Blood. 112, p. 3444-3454

    Research output: Contribution to journalArticle

  49. 2007
  50. 2006
  51. Biosynthesis, processing, and sorting of human myeloperoxidase.

    Markus Hansson, Inge Olsson & Nauseef, W. M., 2006, In : Archives of Biochemistry and Biophysics. 445, 2, p. 214-224

    Research output: Contribution to journalReview article

  52. Neutrophil elastase sorting involves plasma membrane trafficking requiring the C-terminal propeptide.

    Tapper, H., Källquist, L., Ellinor Johnsson, Persson, A-M., Markus Hansson & Inge Olsson, 2006, In : Experimental Cell Research. 312, 18, p. 3471-3484

    Research output: Contribution to journalArticle

  53. 2005
Previous 1 2 Next